Trademarkia Logo

Canada

C$
RETHINKDEPRESSION & DESIGN
REGISTERED

on 3 Sept 2019

Last Applicant/ Owned by

H. LUNDBECK A/S

Ottiliavej 92500 Valby

DK

Serial Number

1839031 filed on 24th May 2017

Registration Number

TMA1052153 registered on 3rd Sept 2019

Registration expiry Date

3rd Sept 2029

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

RETHINKDEPRESSION & DESIGN

Trademark usage description

medical, clinical, therapeutic and healthcare services, namely medical clinic services, medical and surgical diagnostic services, medical screening, m Read More

Vienna Information


1 . 15 . 21

Bubbles, frothy masses -- Note: Including speech bubbles.Bulles, masses mousseuses -- Note: Y compris les bulles de bandes dessinées.

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information


Class [044]
Provision of medical, clinical, therapeutic and healthcare information services relating to the prevention and treatment of disorders and diseases in the central nervous system, namely Alzheimer's disease, depression, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease, insomnia, Parkinson's disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and addiction, and psychiatric and neurological disorders and diseases; advice related to medical and pharmaceutical preparations and substances for the treatment of central nervous system disease and disorders, namely, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; providing medical and medicinal information in the fields of diagnostic and therapeutic properties of pharmaceuticals for the prevention and treatment of disorders and diseases in the central nervous system, namely Alzheimer's disease, depression, psychosis, anxiety, epilepsy, multiple sclerosis, porphyria, Huntington's disease, insomnia, Parkinson's disease, schizophrenia, bipolar disorder, oncology, pain, alcoholism and addiction, and psychiatric and neurological disorders and diseases.


Classification kind code

11

Mark Details


Serial Number

1839031

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 27th Jun 2019
Registration Pending
Submitted for opposition 191
on 27th Jun 2019
Registration Fee Notice Sent
Submitted for opposition 42
on 3rd Apr 2019
Advertised
Submitted for opposition 26
on 14th Mar 2019
Approved
Submitted for opposition 27
on 25th Jan 2019
Approval Notice Sent
Submitted for opposition 22
on 7th May 2018
Search Recorded
Submitted for opposition 20
on 7th May 2018
Examiner's First Report
Submitted for opposition 31
on 29th May 2017
Formalized
Submitted for opposition 30
on 24th May 2017
Filed
Submitted for opposition 1
on 24th May 2017
Created